Main Menu


Publications Highlights View all by category

Types of Publications

Journal Articles

Flaherty, R.L. Sflomos, G. Brisken, C. (2024). Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?. Endocrinology, Vol.165 (5).  show abstract

Ronchi, C. Brisken, C. (2023). Targeting the Progesterone Receptor in Breast Cancer: Mind the Short Form!. Clin cancer res, Vol.29 (5), pp. 833-834.  show abstract  full text

Gibson, S.V. Tomas Bort, E. Rodríguez-Fernández, L. Allen, M.D. Gomm, J.J. Goulding, I. Auf dem Keller, U. Agnoletto, A. Brisken, C. Peck, B. Cameron, A.J. Marshall, J.F. Jones, J.L. Carter, E.P. Grose, R.P. (2023). TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression. Npj breast cancer, Vol.9 (1), p. 9.  show abstract  full text

Sflomos, G. Schaumann, N. Christgen, M. Christgen, H. Bartels, S. Kreipe, H. Battista, L. Brisken, C. (2023). Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma. Cancers (basel), Vol.15 (13).  show abstract  full text

Aouad, P. Quinn, H.M. Berger, A. Brisken, C. (2023). Tumor dormancy: EMT beyond invasion and metastasis. Genesis, , p. e23552.  show abstract

Scabia, V. Ayyanan, A. De Martino, F. Agnoletto, A. Battista, L. Laszlo, C. Treboux, A. Zaman, K. Stravodimou, A. Jallut, D. Fiche, M. Bucher, P. Ambrosini, G. Sflomos, G. Brisken, C. (2022). Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. Nat commun, Vol.13 (1), p. 3127.  show abstract  full text

Bernier-Latmani, J. Mauri, C. Marcone, R. Renevey, F. Durot, S. He, L. Vanlandewijck, M. Maclachlan, C. Davanture, S. Zamboni, N. Knott, G.W. Luther, S.A. Betsholtz, C. Delorenzi, M. Brisken, C. Petrova, T.V. (2022). ADAMTS18+ villus tip telocytes maintain a polarized VEGFA signaling domain and fenestrations in nutrient-absorbing intestinal blood vessels. Nat commun, Vol.13 (1), p. 3983.  show abstract  full text

Staaf, J. Häkkinen, J. Hegardt, C. Saal, L.H. Kimbung, S. Hedenfalk, I. Lien, T. Sørlie, T. Naume, B. Russnes, H. Marcone, R. Ayyanan, A. Brisken, C. Malterling, R.R. Asking, B. Olofsson, H. Lindman, H. Bendahl, P.-. Ehinger, A. Larsson, C. Loman, N. Rydén, L. Malmberg, M. Borg, Å. Vallon-Christersson, J. (2022). RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. Npj breast cancer, Vol.8 (1), p. 94.  show abstract  full text

Aouad, P. Zhang, Y. De Martino, F. Stibolt, C. Ali, S. Ambrosini, G. Mani, S.A. Maggs, K. Quinn, H.M. Sflomos, G. Brisken, C. (2022). Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence. Nat commun, Vol.13 (1), p. 4975.  show abstract  full text

Sflomos, G. Battista, L. Aouad, P. De Martino, F. Scabia, V. Stravodimou, A. Ayyanan, A. Ifticene-Treboux, A. RLS, Bucher, P. Fiche, M. Ambrosini, G. Brisken, C. (2021). Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1. Embo mol med, Vol.13 (3), p. e13180.  show abstract  full text

Juppet, Q. De Martino, F. Marcandalli, E. Weigert, M. Burri, O. Unser, M. Brisken, C. Sage, D. (2021). Deep Learning Enables Individual Xenograft Cell Classification in Histological Images by Analysis of Contextual Features. J mammary gland biol neoplasia, Vol.26 (2), pp. 101-112.  show abstract  full text

Shamseddin, M. De Martino, F. Constantin, C. Scabia, V. Lancelot, A.-. Laszlo, C. Ayyannan, A. Battista, L. Raffoul, W. Gailloud-Matthieu, M.-. Bucher, P. Fiche, M. Ambrosini, G. Sflomos, G. Brisken, C. (2021). Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation. Embo mol med, Vol.13 (7), p. e14314.  show abstract  full text

Sflomos, G. Schipper, K. Koorman, T. Fitzpatrick, A. Oesterreich, S. Lee, A.V. Jonkers, J. Brunton, V.G. Christgen, M. Isacke, C. Derksen, P.W. Brisken, C. (2021). Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers (basel), Vol.13 (21).  show abstract  full text

Koch, C. Kuske, A. Joosse, S.A. Yigit, G. Sflomos, G. Thaler, S. Smit, D.J. Werner, S. Borgmann, K. Gärtner, S. Mossahebi Mohammadi, P. Battista, L. Cayrefourcq, L. Altmüller, J. Salinas-Riester, G. Raithatha, K. Zibat, A. Goy, Y. Ott, L. Bartkowiak, K. Tan, T.Z. Zhou, Q. Speicher, M.R. Müller, V. Gorges, T.M. Jücker, M. Thiery, J.-. Brisken, C. Riethdorf, S. Alix-Panabières, C. Pantel, K. (2020). Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. Embo mol med, Vol.12 (9), p. e11908.  show abstract  full text

Brisken, C. Scabia, V. (2020). 90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer. J mol endocrinol, Vol.65 (1), pp. T81-T94.  show abstract  full text

Gagniac, L. Rusidzé, M. Boudou, F. Cagnet, S. Adlanmerini, M. Jeannot, P. Gaide, N. Giton, F. Besson, A. Weyl, A. Gourdy, P. Raymond-Letron, I. Arnal, J.-. Brisken, C. Lenfant, F. (2020). Membrane expression of the estrogen receptor ERα is required for intercellular communications in the mammary epithelium. Development, Vol.147 (5).  show abstract  full text

Siersbæk, R. Scabia, V. Nagarajan, S. Chernukhin, I. Papachristou, E.K. Broome, R. Johnston, S.J. Joosten, S.E. Green, A.R. Kumar, S. Jones, J. Omarjee, S. Alvarez-Fernandez, R. Glont, S. Aitken, S.J. Kishore, K. Cheeseman, D. Rakha, E.A. D'Santos, C. Zwart, W. Russell, A. Brisken, C. Carroll, J.S. (2020). IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis. Cancer cell, Vol.38 (3), pp. 412-423.e9.  show abstract  full text

Cartaxo, A.L. Estrada, M.F. Domenici, G. Roque, R. Silva, F. Gualda, E.J. Loza-Alvarez, P. Sflomos, G. Brisken, C. Alves, P.M. André, S. Brito, C. (2020). A novel culture method that sustains ERα signaling in human breast cancer tissue microstructures. J exp clin cancer res, Vol.39 (1), p. 161.  show abstract  full text

Ataca, D. Aouad, P. Constantin, C. Laszlo, C. Beleut, M. Shamseddin, M. Rajaram, R.D. Jeitziner, R. Mead, T.J. Caikovski, M. Bucher, P. Ambrosini, G. Apte, S.S. Brisken, C. (2020). The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche. Nat commun, Vol.11 (1), p. 1571.  show abstract  full text

Fiche, M. Scabia, V. Aouad, P. Battista, L. Treboux, A. Stravodimou, A. Zaman, K. RLS, Dormoy, V. Ayyanan, A. Sflomos, G. Brisken, C. (2019). Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions. J pathol, Vol.247 (3), pp. 287-292.  show abstract  full text

Jeitziner, R. Carrière, M. Rougemont, J. Oudot, S. Hess, K. Brisken, C. (2019). Two-Tier Mapper, an unbiased topology-based clustering method for enhanced global gene expression analysis. Bioinformatics, Vol.35 (18), pp. 3339-3347.  show abstract

Nacht, A.S. Ferrari, R. Zaurin, R. Scabia, V. Carbonell-Caballero, J. Le Dily, F. Quilez, J. Leopoldi, A. Brisken, C. Beato, M. Vicent, G.P. (2019). C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells. Embo j, Vol.38 (18), p. e101426.  show abstract  full text

Laszlo, C.F. Paz Montoya, J. Shamseddin, M. De Martino, F. Beguin, A. Nellen, R. Bruce, S.J. Moniatte, M. Henry, H. Brisken, C. (2019). A high resolution LC-MS targeted method for the concomitant analysis of 11 contraceptive progestins and 4 steroids. J pharm biomed anal, Vol.175, p. 112756.  show abstract  full text

Özdemir, B.C. Sflomos, G. Brisken, C. (2018). The challenges of modeling hormone receptor-positive breast cancer in mice. Endocr relat cancer, Vol.25 (5), pp. R319-R330.  show abstract

Cagnet, S. Ataca, D. Sflomos, G. Aouad, P. Schuepbach-Mallepell, S. Hugues, H. Krust, A. Ayyanan, A. Scabia, V. Brisken, C. (2018). Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium. Nat commun, Vol.9 (1), p. 4723.  show abstract  full text

George, A.L. Boulanger, C.A. Anderson, L.H. Cagnet, S. Brisken, C. Smith, G.H. (2017). In vivo reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. J cell sci, Vol.130 (12), pp. 2018-2025.  show abstract  full text

Dobrolecki, L.E. Airhart, S.D. Alferez, D.G. Aparicio, S. Behbod, F. Bentires-Alj, M. Brisken, C. Bult, C.J. Cai, S. Clarke, R.B. Dowst, H. Ellis, M.J. Gonzalez-Suarez, E. Iggo, R.D. Kabos, P. Li, S. Lindeman, G.J. Marangoni, E. McCoy, A. Meric-Bernstam, F. Piwnica-Worms, H. Poupon, M.-. Reis-Filho, J. Sartorius, C.A. Scabia, V. Sflomos, G. Tu, Y. Vaillant, F. Visvader, J.E. Welm, A. Wicha, M.S. Lewis, M.T. (2016). Patient-derived xenograft (PDX) models in basic and translational breast cancer research. Cancer metastasis rev, Vol.35 (4), pp. 547-573.  show abstract  full text

Sflomos, G. Dormoy, V. Metsalu, T. Jeitziner, R. Battista, L. Scabia, V. Raffoul, W. Delaloye, J.-. Treboux, A. Fiche, M. Vilo, J. Ayyanan, A. Brisken, C. (2016). A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response. Cancer cell, Vol.29 (3), pp. 407-422.  show abstract

Ataca, D. Caikovski, M. Piersigilli, A. Moulin, A. Benarafa, C. Earp, S.E. Guri, Y. Kostic, C. Arsenivic, Y. Soininen, R. Apte, S.S. Brisken, C. (2016). Adamts18 deletion results in distinct developmental defects and provides a model for congenital disorders of lens, lung, and female reproductive tract development. Biology open, Vol.5, pp. 1585-1594.  show abstract  full text

Blom, S. Wang, Y. Metsalu, T. Vesterinen, T. Pellinen, T. Grote, A. Linder, N. Säilä, J. Välimäki, K. Kovanen, R.-. Monni, O. Kovanen, P. Davies, E. Stock, K. Estrada, M. Sflomos, G. Grünewald, S. Brito, C. Schüler, J. de Hoogt, R. Brisken, C. van der Kuip, H. van Weerden, W. Barry, S. Sommergruber, W. Anderson, E. Nees, M. Klefström, J. Vilo, J. Verschuren, E. Graeser, R. Hickman, J. Lundin, J. Kallioniemi, O. (2015). Abstract 1698: Systems pathology for characterization of cancer model systems in a multicenter IMI-PREDECT project. Cancer research, Vol.75 (15_Supplement), pp. 1698-1698.  show abstract

Rajaram, R.D. Buric, D. Caikovski, M. Ayyanan, A. Rougemont, J. Shan, J. Vainio, S.J. Yalcin-Ozuysal, O. Brisken, C. (2015). Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. Embo j, Vol.34 (5), pp. 641-652.  show abstract  full text

Sflomos, G. Shamsheddin, M. Brisken, C. (2015). An ex vivo model to study hormone action in the human breast. J vis exp, (95), p. e52436.  show abstract  full text

Procopio, M.-. Laszlo, C. Al Labban, D. Kim, D.E. Bordignon, P. Jo, S.-. Goruppi, S. Menietti, E. Ostano, P. Ala, U. Provero, P. Hoetzenecker, W. Neel, V. Kilarski, W.W. Swartz, M.A. Brisken, C. Lefort, K. Dotto, G.P. (2015). Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat cell biol, Vol.17 (9), pp. 1193-1204.  show abstract  full text

Brisken, C. Hess, K. Jeitziner, R. (2015). Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis. Endocrinology, Vol.156 (10), pp. 3442-3450.  show abstract

Brisken, C. Ataca, D. (2015). Endocrine hormones and local signals during the development of the mouse mammary gland. Wiley interdiscip rev dev biol, Vol.4 (3), pp. 181-195.  show abstract

Cimino, D. De Pittà, C. Orso, F. Zampini, M. Casara, S. Penna, E. Quaglino, E. Forni, M. Damasco, C. Pinatel, E. Ponzone, R. Romualdi, C. Brisken, C. De Bortoli, M. Biglia, N. Provero, P. Lanfranchi, G. Taverna, D. (2013). miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. Faseb j, Vol.27 (3), pp. 1223-1235.  show abstract

Brisken, C. (2013). Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat rev cancer, Vol.13 (6), pp. 385-396.  show abstract

Soto, A.M. Brisken, C. Schaeberle, C. Sonnenschein, C. (2013). Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J mammary gland biol neoplasia, Vol.18 (2), pp. 199-208.  show abstract

Tanos, T. Sflomos, G. Echeverria, P.C. Ayyanan, A. Gutierrez, M. Delaloye, J.-. Raffoul, W. Fiche, M. Dougall, W. Schneider, P. Yalcin-Ozuysal, O. Brisken, C. (2013). Progesterone/RANKL is a major regulatory axis in the human breast. Sci transl med, Vol.5 (182), p. 182ra55.  show abstract

Tanos, T. Rojo, L. Echeverria, P. Brisken, C. (2012). ER and PR signaling nodes during mammary gland development. Breast cancer res, Vol.14 (4), p. 210.  show abstract

Rajaram, R.D. Brisken, C. (2012). Paracrine signaling by progesterone. Mol cell endocrinol, Vol.357 (1-2), pp. 80-90.  show abstract

Ayyanan, A. Laribi, O. Schuepbach-Mallepell, S. Schrick, C. Gutierrez, M. Tanos, T. Lefebvre, G. Rougemont, J. Yalcin-Ozuysal, O. Brisken, C. (2011). Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. Mol endocrinol, Vol.25 (11), pp. 1915-1923.  show abstract

Dong, J. Huang, S. Caikovski, M. Ji, S. McGrath, A. Custorio, M.G. Creighton, C.J. Maliakkal, P. Bogoslovskaia, E. Du, Z. Zhang, X. Lewis, M.T. Sablitzky, F. Brisken, C. Li, Y. (2011). ID4 regulates mammary gland development by suppressing p38MAPK activity. Development, Vol.138 (23), pp. 5247-5256.  show abstract

Booth, B.W. Boulanger, C.A. Anderson, L.H. Jimenez-Rojo, L. Brisken, C. Smith, G.H. (2010). Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp cell res, Vol.316 (3), pp. 422-432.  show abstract

Dietrich, C. Weiss, C. Bockamp, E. Brisken, C. Roskams, T. Morris, R. Oesch-Bartlomowicz, B. Oesch, F. (2010). Stem cells in chemical carcinogenesis. Arch toxicol, Vol.84 (3), pp. 245-251.

Yang, C. Chen, L. Li, C. Lynch, M.C. Brisken, C. Schmidt, E.V. (2010). Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. Mol cell biol, Vol.30 (12), pp. 3111-3125.  show abstract  full text

Battula, V.L. Evans, K.W. Hollier, B.G. Shi, Y. Marini, F.C. Ayyanan, A. Wang, R.-. Brisken, C. Guerra, R. Andreeff, M. Mani, S.A. (2010). Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem cells, Vol.28 (8), pp. 1435-1445.  show abstract

Yalcin-Ozuysal, O. Fiche, M. Guitierrez, M. Wagner, K.-. Raffoul, W. Brisken, C. (2010). Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates. Cell death differ, Vol.17 (10), pp. 1600-1612.  show abstract

Brisken, C. O'Malley, B. (2010). Hormone action in the mammary gland. Cold spring harb perspect biol, Vol.2 (12), p. a003178.  show abstract

Hu, B. Lefort, K. Qiu, W. Nguyen, B.-. Rajaram, R.D. Castillo, E. He, F. Chen, Y. Angel, P. Brisken, C. Dotto, G.P. (2010). Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis. Genes dev, Vol.24 (14), pp. 1519-1532.  show abstract

Beleut, M. Rajaram, R.D. Caikovski, M. Ayyanan, A. Germano, D. Choi, Y. Schneider, P. Brisken, C. (2010). Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc natl acad sci u s a, Vol.107 (7), pp. 2989-2994.  show abstract

Cicalese, A. Bonizzi, G. Pasi, C.E. Faretta, M. Ronzoni, S. Giulini, B. Brisken, C. Minucci, S. Di Fiore, P.P. Pelicci, P.G. (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell, Vol.138 (6), pp. 1083-1095.  show abstract

Yalcin-Ozuysal, O. Brisken, C. (2009). From normal cell types to malignant phenotypes. Breast cancer res, Vol.11 (6), p. 306.  show abstract

Barbaroux, J.-. Beleut, M. Brisken, C. Mueller, C.G. Groves, R.W. (2008). Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation. J immunol, Vol.181 (2), pp. 1103-1108.  show abstract

Boulay, A. Breuleux, M. Stephan, C. Fux, C. Brisken, C. Fiche, M. Wartmann, M. Stumm, M. Lane, H.A. Hynes, N.E. (2008). The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. Cancer res, Vol.68 (10), pp. 3743-3751.  show abstract

Mani, S.A. Guo, W. Liao, M.-. Eaton, E.N. Ayyanan, A. Zhou, A.Y. Brooks, M. Reinhard, F. Zhang, C.C. Shipitsin, M. Campbell, L.L. Polyak, K. Brisken, C. Yang, J. Weinberg, R.A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, Vol.133 (4), pp. 704-715.  show abstract

Tanos, T. Brisken, C. (2008). What signals operate in the mammary niche?. Breast dis, Vol.29, pp. 69-82.  show abstract

Brisken, C. Duss, S. (2007). Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem cell rev, Vol.3 (2), pp. 147-156.  show abstract

Ciarloni, L. Mallepell, S. Brisken, C. (2007). Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc natl acad sci u s a, Vol.104 (13), pp. 5455-5460.  show abstract  full text

Duss, S. André, S. Nicoulaz, A.-. Fiche, M. Bonnefoi, H. Brisken, C. Iggo, R.D. (2007). An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells. Breast cancer res, Vol.9 (3), p. R38.  show abstract

Ayyanan, A. Civenni, G. Ciarloni, L. Morel, C. Mueller, N. Lefort, K. Mandinova, A. Raffoul, W. Fiche, M. Dotto, G.P. Brisken, C. (2006). Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc natl acad sci u s a, Vol.103 (10), pp. 3799-3804.  show abstract  full text

Brisken, C. Rajaram, R.D. (2006). Alveolar and lactogenic differentiation. J mammary gland biol neoplasia, Vol.11 (3-4), pp. 239-248.  show abstract

Mallepell, S. Krust, A. Chambon, P. Brisken, C. (2006). Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc natl acad sci u s a, Vol.103 (7), pp. 2196-2201.  show abstract

Farmer, P. Bonnefoi, H. Becette, V. Tubiana-Hulin, M. Fumoleau, P. Larsimont, D. Macgrogan, G. Bergh, J. Cameron, D. Goldstein, D. Duss, S. Nicoulaz, A.-. Brisken, C. Fiche, M. Delorenzi, M. Iggo, R. (2005). Identification of molecular apocrine breast tumours by microarray analysis. Oncogene, Vol.24 (29), pp. 4660-4671.  show abstract

Devgan, V. Mammucari, C. Millar, S.E. Brisken, C. Dotto, G.P. (2005). p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes dev, Vol.19 (12), pp. 1485-1495.  show abstract

Chu, E.Y. Hens, J. Andl, T. Kairo, A. Yamaguchi, T.P. Brisken, C. Glick, A. Wysolmerski, J.J. Millar, S.E. (2004). Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development, Vol.131 (19), pp. 4819-4829.  show abstract

Gass, S. Harris, J. Ormandy, C. Brisken, C. (2003). Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function. J mammary gland biol neoplasia, Vol.8 (3), pp. 269-285.  show abstract

Brisken, C. Ayyannan, A. Nguyen, C. Heineman, A. Reinhardt, F. Tan, J. Dey, S.K. Dotto, G.P. Weinberg, R.A. (2002). IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev cell, Vol.3 (6), pp. 877-887.  show abstract

Brisken, C. Socolovsky, M. Lodish, H.F. Weinberg, R. (2002). The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium. Proc natl acad sci u s a, Vol.99 (22), pp. 14241-14245.  show abstract  full text

Brisken, C. Ayyanan, A. Doppler, W. (2002). Prolactin signaling and Stat5: going their own separate ways?. Breast cancer res, Vol.4 (6), pp. 209-212.  show abstract

Brisken, C. Heineman, A. Chavarria, T. Elenbaas, B. Tan, J. Dey, S.K. McMahon, J.A. McMahon, A.P. Weinberg, R.A. (2000). Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes dev, Vol.14 (6), pp. 650-654.  show abstract

Brisken, C. Kaur, S. Chavarria, T.E. Binart, N. Sutherland, R.L. Weinberg, R.A. Kelly, P.A. Ormandy, C.J. (1999). Prolactin controls mammary gland development via direct and indirect mechanisms. Dev biol, Vol.210 (1), pp. 96-106.  show abstract

Brisken, C. Endocrine Disruptors and Breast Cancer. Chimia, Vol.62 (5), pp. 406-406.  show abstract

In this section

Research overview Research projects Publications